Answers are grounded in this paper and cite their sources.
Demonstrates accurate HLA class I epitope prediction, suggesting advances in personalized vaccines.
Accurate identification of human leukocyte antigen (HLA) class I-presented epitopes is essential for developing personalized vaccines and immunotherapies. Here, we present HLABrew, a unified deep learning framework for HLA class I epitope prediction and allele-specific mimotope design. By integrating the Transformer, variational autoencoder, and dual cross-attention, HLABrew achieves state-of-the-art performance with hierarchical and allele-aware representations. HLABrew accurately deconvolves multiallelic immunopeptidomics data to recover allele-specific binding motifs and expand epitope coverage. Leveraging its generative capacity, HLABrew further designs mimotopes guided by learned peptide-HLA binding preferences, with the potential to enhance antigen presentation and provide candidates for downstream immunogenicity evaluation.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: